Log In
Print this Print this

MaterniT21 Plus (MaterniT21 laboratory-developed test (LDT)) (formerly DNA-based Down syndrome test)

Also known as: MaterniT21 Plus test

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
DescriptionNon-invasive prenatal fetal trisomy 21, 18 and 13 test that utilizes multiplexed massively parallel shotgun sequencing of circulating cell-free fetal DNA in maternal plasma
Molecular Target DNA
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect fetal aneuploidy in pregnant women
Regulatory Designation
PartnerEnzo Biochem Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today